www.evonetix.com/Healthcare / BioTech & PharmaFounded: 2015
Founded in 2015, Evonetix is pioneering gene synthesis technology by integrating silicon chip manufacturing scalability into benchtop DNA synthesis. This innovative approach aims to produce gene-length DNA with unparalleled accuracy and speed, overcoming current technological constraints. Evonetix's mission is to enable scientists to address global challenges in healthcare, agriculture, and sustainability more effectively. By facilitating access to accurate, long DNA strands, the company aspires to advance synthetic biology applications significantly. Evonetix envisions its gene synthesis platform becoming essential in labs worldwide, revolutionizing how biological research and applications are approached.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Evonetix.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.